“No Time to Die,” the latest installment in the James Bond franchise, debuted to $56 million from 4,407 theaters at the domestic box office. The result falls somewhat short of expectations and signals that even one of the most storied brands in film history is still being forced to contend with a moviegoing landscape that has been dramatically altered by the pandemic.
Heading into the weekend, “No Time to Die” was projected to make $60 million to $70 million in its first three days of release. Though not a disaster, the film’s final weekend total was expected to be higher because it received positive reviews and represented Daniel Craig’s final outing as the stylish secret agent.
In light of the ongoing pandemic, assessing initial box office results for “No Time to Die” isn’t as clear-cut. For some movies, especially during a public health crisis, an opening weekend of $56 million would be cause for great jubilation. But “No Time to Die” is no ordinary film. It carries a massive $250 million production budget, to say nothing of the more than $100 million marketing spend. Add in the tens of millions it cost to delay “No Time to Die,” which was supposed to premiere in April of 2020 before the pandemic altered those plans, and box office experts estimate that, conservatively, “No Time to Die” needs to gross at least $800 million at the global box office to make money in its theatrical window. For Bond, the franchise has numerous marketing partners and ancillary tie-ins, with Rolex, Aston Martin and more, that could help cushion potential losses.
Ticket sales at the international box office will be a huge factor in terms of profitability for “No Time to Die.” So far, audiences have been turning out overseas, where it has already made an impressive $145 million. Globally, the film has collected $313 million. Directed by Cary Joji Fukunaga (“True Detective”) and co-starring Lea Seydoux, Rami Malek and Ana de Armas, the 007 adventure has opened in most major markets except for China (set for Oct. 29), a popular territory for all things Bond.
At the domestic box office, “No Time to Die’s” start ranks below recent series entries 2015’s “Spectre ($70 million) and 2012’s franchise-high “Skyfall” ($88 Million). The slightly muted results for “No Time to Die” are attributable to several factors, including hesitation among older audiences to return to theaters and its lengthy two-hour-and-45-minute runtime, which limited the number of screenings per day. It’s also the first Hollywood tentpole with real competition at the box office. Sony’s comic book sequel “Venom: Let There Be Carnage” opened last weekend and has continued to pull in crowds, which may have cannibalized ticket sales for Bond.
With “No Time to Die” claiming the No. 1 spot on domestic box office charts, the “Venom” follow-up slid to second place with $32 million, a figure that’s more than many pandemic-era releases have made in their entire theatrical run. In total, “Venom: Let There Be Carnage” has generated a mighty $141 million in North America and $185 million worldwide.
Since Bond is a property that tends to skew toward older audiences, box office analysts haven’t been discouraged by the turnout for “No Time to Die.” In general, older moviegoers don’t make as much of an effort to watch a film on its opening weekend. Exit polls indicates that 64% of ticket buyers were male and 57% were over the age of 35. It scored an “A-” CinemaScore, a positive sign for the movie’s long-term prospects.
One promising note for the future of moviegoing: 25% of ticket buyers returned to theaters for the first time in more than 18 months for Bond, according to United Artists Releasing, the company distributing “No Time to Die” in the U.S. Universal is distributing the film in most international territories, as well as Canada.
“The audience is broad, with all age groups and segments well-represented, including the 35+ crowd, who have been slow to return to the movies,” says David A. Gross, who runs the movie consulting firm Franchise Entertainment Research. “If anything kept the film from over-performing this weekend, it is the younger groups, who are less committed to the series.”
In a distant third place on domestic charts, “The Addams Family 2” generated $10 million, bringing its North American total to $31.1 million. The animated family comedy, from MGM and United Artists Releasing, is being offered simultaneously on premium video-on-demand platforms.
Disney’s superhero adventure “Shang-Chi and the Legend of the Ten Rings” landed at No. 4 with $4.2 million in its sixth weekend in theaters. Globally, the Marvel comic book adaptation has surpassed $400 million worldwide, making it the sixth-highest grossing film of the year. With $212 million in North America, it remains the biggest movie of 2021 at the domestic box office.
“The Many Saints of Newark,” a prequel to “The Sopranos,” rounded out the top five with a paltry $1.4 million in its sophomore outing. That puts ticket sales for the Warner Bros. movie, which premiered day-and-date on HBO Max, at a dismal $7.4 million. It cost $50 million to make.